|
|
|
Insider
Information: |
Mostafa Adam S. |
Relationship: |
Chief Financial Officer |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
X4 Pharmaceuticals Inc |
XFOR |
Chief Financial Officer |
2024-03-11 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2024-03-11 |
4 |
S |
$0.88 |
$46,347 |
D/D |
(52,500) |
0 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2024-02-12 |
4 |
AS |
$1.01 |
$27,973 |
D/D |
(27,721) |
52,500 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2023-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
230,645 |
310,866 |
0 |
- |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2023-06-30 |
4 |
AS |
$1.89 |
$4,991 |
D/D |
(2,641) |
80,221 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2023-06-23 |
4 |
AS |
$1.93 |
$10,455 |
D/D |
(5,417) |
82,862 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2023-06-15 |
4 |
AS |
$2.22 |
$12,026 |
D/D |
(5,417) |
88,279 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2023-03-10 |
4 |
AS |
$0.84 |
$44,100 |
D/D |
(52,500) |
93,696 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2023-02-13 |
4 |
AS |
$0.93 |
$25,781 |
D/D |
(27,721) |
146,196 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2022-08-17 |
4 |
AS |
$0.00 |
$0 |
D/D |
(10,834) |
173,917 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2022-06-30 |
4 |
AS |
$0.00 |
$0 |
D/D |
(2,641) |
184,751 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2022-06-24 |
4 |
AS |
$0.00 |
$0 |
D/D |
(5,416) |
187,392 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2022-06-16 |
4 |
AS |
$0.00 |
$0 |
D/D |
(5,416) |
192,808 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
198,224 |
0 |
- |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2022-02-11 |
4 |
AS |
$0.00 |
$0 |
D/D |
(27,721) |
93,224 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2021-08-17 |
4 |
AS |
$5.10 |
$55,243 |
D/D |
(10,832) |
120,945 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2021-06-30 |
4 |
AS |
$6.64 |
$17,536 |
D/D |
(2,641) |
131,777 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2021-06-24 |
4 |
AS |
$7.01 |
$37,973 |
D/D |
(5,417) |
134,418 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2021-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
139,835 |
0 |
- |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2021-06-15 |
4 |
AS |
$7.84 |
$42,469 |
D/D |
(5,417) |
123,585 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
129,002 |
0 |
- |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2021-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
83,163 |
112,752 |
0 |
- |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2020-09-21 |
4 |
AS |
$7.08 |
$76,705 |
D/D |
(10,834) |
29,589 |
0 |
% |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2020-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
40,423 |
0 |
- |
|
XFOR |
X4 Pharmaceuticals Inc |
Chief Financial Officer |
|
2020-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
24,173 |
0 |
- |
|
XFOR |
X4 Pharmaceuticals Inc |
See Remarks |
|
2020-06-30 |
4 |
D |
$9.32 |
$8,537 |
D/D |
(916) |
7,923 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|